Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 796 · Second Chance for Moms Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 352 Misbranded drugs and devices

+2 −0Shown
More for 21 U.S.C. § 352
Read § 352Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:(hh) If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: “WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance …

§ 352(gg)–(hh)

Start of § 352 to (gg)(2)(E) unchanged ·

(F) product-related programs or services; and

(G) factual presentations of results from studies that do not characterize or make conclusions regarding safety or efficacy.

(hh) [inserted: If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: “WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance of fetal survival. The American Society for Reproductive Medicine has determined that natural progesterone is safe in the first trimester of pregnancy. For more information, call [___].” (with the blank filled in to refer to the appropriate number for the hotline under section 1009 of the Public Health Service Act).]

Step through the changes